SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000014272-17-000195
Filing Date
2017-10-26
Accepted
2017-10-26 11:27:47
Documents
76
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmy-20170930x10q.htm 10-Q 1848011
2 COMPUTATION OF EARNINGS TO FIXED CHARGES bmyex12_20170930.htm EX-12 73901
3 EXHIBIT 31.A bmyex31a_20170930.htm EX-31.A 11618
4 EXHIBIT 31.B bmyex31b_20170930.htm EX-31.B 11831
5 EXHIBIT 32.A bmyex32a_20170930.htm EX-32.A 3944
6 EXHIBIT 32.B bmyex32b_20170930.htm EX-32.B 3944
  Complete submission text file 0000014272-17-000195.txt   9889587

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bmy-20170930.xml EX-101.INS 2476938
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20170930.xsd EX-101.SCH 62182
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20170930_cal.xml EX-101.CAL 129550
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20170930_def.xml EX-101.DEF 260888
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20170930_lab.xml EX-101.LAB 840727
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20170930_pre.xml EX-101.PRE 446089
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-01136 | Film No.: 171155382
SIC: 2834 Pharmaceutical Preparations